➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Medtronic
Baxter
Express Scripts
Johnson and Johnson

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

MACRODANTIN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Macrodantin patents expire, and when can generic versions of Macrodantin launch?

Macrodantin is a drug marketed by Alvogen and is included in one NDA.

The generic ingredient in MACRODANTIN is nitrofurantoin, macrocrystalline. Twenty suppliers are listed for this compound. Additional details are available on the nitrofurantoin, macrocrystalline profile page.

Drug patent expirations by year for MACRODANTIN
Drug Prices for MACRODANTIN

See drug prices for MACRODANTIN

Drug Sales Revenue Trends for MACRODANTIN

See drug sales revenues for MACRODANTIN

Recent Clinical Trials for MACRODANTIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Glasgow Caledonian UniversityPhase 4
North Bristol NHS TrustPhase 4
Newcastle-upon-Tyne Hospitals NHS TrustPhase 4

See all MACRODANTIN clinical trials

Pharmacology for MACRODANTIN

US Patents and Regulatory Information for MACRODANTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen MACRODANTIN nitrofurantoin, macrocrystalline CAPSULE;ORAL 016620-003 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Alvogen MACRODANTIN nitrofurantoin, macrocrystalline CAPSULE;ORAL 016620-001 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Alvogen MACRODANTIN nitrofurantoin, macrocrystalline CAPSULE;ORAL 016620-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Johnson and Johnson
Colorcon
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.